| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/25/2006 | US7081343 Methods for identifying modulators of NF-KB activity |
| 07/25/2006 | US7081342 Using attenuated viral sequence to develop vaccines to prevent porcine reproductive and respiratory syndrome in swine; immunotherapy |
| 07/25/2006 | US7081338 DNA coding for a novel cell adhesion molecule |
| 07/25/2006 | US7081337 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's diseases |
| 07/25/2006 | US7081335 Prolactin receptor gene as a genetic marker for increased litter size in animals |
| 07/25/2006 | US7081257 Gelling vegetable protein |
| 07/25/2006 | US7081245 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 07/25/2006 | US7081244 Genetic engineering; vaccines; induction immunology response, antibodies |
| 07/25/2006 | US7081241 Extracellular rage binding protein (EN-RAGE) and uses thereof |
| 07/25/2006 | CA2188264C Isolated nucleic acid molecule coding for fibroblast activation protein .alpha. and uses thereof |
| 07/20/2006 | WO2006076741A2 Canine 5-hydroxytryptamine 2a and 2b receptor materials and thier use |
| 07/20/2006 | WO2006076735A2 Regulating expression of transient receptor potential channel genes |
| 07/20/2006 | WO2006076596A2 Generation of plants with altered oil content |
| 07/20/2006 | WO2006076417A1 Method for making targeted therapeutic agents |
| 07/20/2006 | WO2006076410A2 Li-key/antigenic epitope hybrid peptide vaccines |
| 07/20/2006 | WO2006076189A2 Maize cyclo1 gene and promoter |
| 07/20/2006 | WO2006076041A2 Pan-her antagonists and methods of use |
| 07/20/2006 | WO2006076014A2 Interferon-alpha constructs for use in the treatment of sars |
| 07/20/2006 | WO2006075253A2 Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides. |
| 07/20/2006 | WO2006075187A2 Animals exhibiting an altered preference for an addictive substance |
| 07/20/2006 | WO2006075172A2 Methods for identifying compounds capable of modulating cftr/ck2 interaction and/or cftr phosphorylation by ck2 |
| 07/20/2006 | WO2006075084A2 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and uses thereof |
| 07/20/2006 | WO2006074964A1 C5a receptor antagonists |
| 07/20/2006 | WO2006074891A2 Proteins containing regulatory t-cells for the therapy and diagnosis of illnesses |
| 07/20/2006 | WO2006074600A1 Modified exendins and uses thereof |
| 07/20/2006 | WO2006051333A3 Leucine-rich repeat (lrr) motif containing proteins |
| 07/20/2006 | WO2006045750A3 T-cell stimulatory peptides from the melanoma-associated chondroitin sulfate proteoglycan and their use |
| 07/20/2006 | WO2006034455A3 Polipeptide compounds for inhibiting angiogenesis and tumor growth |
| 07/20/2006 | WO2006029130A3 Methods of identifying tumor associated glycoproteins |
| 07/20/2006 | WO2005120562A3 Structure-based receptor mimics targeted against bacterial superantigen toxins |
| 07/20/2006 | WO2005117983A3 Carrier conjugates of tnf-peptides |
| 07/20/2006 | WO2005115121A3 Adenylyl cyclase antibodies, compositions and uses thereof |
| 07/20/2006 | WO2005114215A9 Method of improving t cell receptors |
| 07/20/2006 | WO2005111070A3 Mucin3 egf-like domains |
| 07/20/2006 | WO2005098015A3 Process for the production of fine chemicals |
| 07/20/2006 | WO2005095591A3 Novel genes from a biosynthesis gene cluster for aminoglycoside antibiotic synthesis and the thus obtained novel aminoglycoside antibiotics |
| 07/20/2006 | WO2005081858A3 Parkin-associated complex for protecting post-mitotic neurons from excitotoxicity and uses thereof |
| 07/20/2006 | WO2005075508A3 Hyperactive stat molecules and their use in assays employing gene activation |
| 07/20/2006 | WO2005023195A3 Treatment of spinal cord injury |
| 07/20/2006 | WO2005016955A3 Nogo receptor antagonists |
| 07/20/2006 | WO2004099367A3 Methods for producing zinc finger proteins that bind to extended dna target sequences |
| 07/20/2006 | WO2004099366A3 Context sensitive parallel optimization of zinc finger dna binding domains |
| 07/20/2006 | WO2004024862A3 Yeast protein expression secretion system |
| 07/20/2006 | WO2004007672A3 Methods and materials relating to novel polypeptides and polynucleotides |
| 07/20/2006 | WO2004003165A3 Novel polynucleotide and polypeptide sequences and uses thereof |
| 07/20/2006 | WO2003084467A3 Epitope constructs comprising antigen presenting cell targeting mechanisms |
| 07/20/2006 | WO2003066808A3 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells |
| 07/20/2006 | WO2002092619A3 Modified growth hormone |
| 07/20/2006 | US20060162021 Enhanced amylose production in plants |
| 07/20/2006 | US20060162018 Plant transcriptional regulators of disease resistance |
| 07/20/2006 | US20060162013 Promoters functional in plant plastids |
| 07/20/2006 | US20060162006 Polynucleotides and polypeptides in plants |
| 07/20/2006 | US20060162005 Methods for producing transgenic medaka |
| 07/20/2006 | US20060162002 Drug screening; assaying for activators of the heat shock factor 1 (HSF-1) protein, which increases lifespan when overexpressed in an organism; antiaging agents |
| 07/20/2006 | US20060162001 Mammalian grainyhead transcription factors |
| 07/20/2006 | US20060160995 Thrombopoietin proteins with improved properties |
| 07/20/2006 | US20060160994 Containing modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII; for use in the treatment of hemorrhagenic disturbances |
| 07/20/2006 | US20060160993 Compositions and methods for regulating RNA stability using polypyrimidine tract proteins |
| 07/20/2006 | US20060160992 Method of identifying cells expressing a protein having pre-B cell growth-supporting ability |
| 07/20/2006 | US20060160991 Genes and polypeptides relating to prostate cancers |
| 07/20/2006 | US20060160990 Fluorescent protein and chromoprotein |
| 07/20/2006 | US20060160948 Polymer-von Willebrand factor-conjugates |
| 07/20/2006 | US20060160836 Estrogen receptor structure |
| 07/20/2006 | US20060160762 Methods for the treatment, diagnosis, and prognosis of cancer |
| 07/20/2006 | US20060160741 Dimeric TF antagonists |
| 07/20/2006 | US20060160738 Stem cell factor-like proteins and uses thereof |
| 07/20/2006 | US20060160733 Compositions and methods for treating and preventing heart tissue degeneration and uses thereof |
| 07/20/2006 | US20060160732 Compositions and methods for inhibiting cell senescence and hyperproliferative disorders |
| 07/20/2006 | US20060160731 Peptide nucleic acids |
| 07/20/2006 | US20060160730 Administering pro-adrenomedullin N-terminal 20 peptide to induce neovascularization; use in treating coronary artery disease, peripheral vascular disease, and wounds; skin and organ (including heart) grafts |
| 07/20/2006 | US20060160729 Methods and compositions for manipulating the guided navigation of endothelial tubes during angiogenesis |
| 07/20/2006 | US20060160728 Diagnostic and therapeutic use of ensandin-0138 gene and protein for neurodegenerative diseases |
| 07/20/2006 | US20060160726 Cyclic agonists and antagonists of C5a receptors and G protein-coupled receptors |
| 07/20/2006 | US20060160724 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 07/20/2006 | US20060160723 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 07/20/2006 | US20060160233 Ig heavy chain, ig kappa, ig lambda biopolymer markers predictive of alzheimers disease |
| 07/20/2006 | US20060160232 Complement c3 precursor biopolymer markers predictive of type ii diabetes |
| 07/20/2006 | US20060160219 Method of transferring mutation into target nucleic acid |
| 07/20/2006 | US20060160218 Transdifferentiation of cells and tissues |
| 07/20/2006 | US20060160212 Process for isolating haemocyanin |
| 07/20/2006 | US20060160211 Transgenic mice containing, cGMP phosphodiesterase gene disruptions |
| 07/20/2006 | US20060160187 Combinatorial interleukin-2 muteins |
| 07/20/2006 | US20060160186 Nucleic acid underexpressed in stomach tumor and lung tumor |
| 07/20/2006 | US20060160182 Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production |
| 07/20/2006 | US20060160181 Fibroblast Growth Factor-23 molecules and uses thereof |
| 07/20/2006 | US20060160179 Filamentous fungal host cells to produce glycans without mannosylphosphate residues, therapy |
| 07/20/2006 | US20060160177 Peptide extended glycosylated polypeptides |
| 07/20/2006 | US20060160176 High throughput cell-based functional assays and using cells, e.g., HEK-293 cells that express a G protein such as G alpha 15, G alpha 16 or gustducin. |
| 07/20/2006 | US20060160159 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/20/2006 | US20060160158 Target and method for inhibition of bacterial rna polymerase |
| 07/20/2006 | US20060160157 Method, compositions and classification for tumor diagnostics and treatment |
| 07/20/2006 | US20060160154 Materials and methods for detection and treatment of breast cancer |
| 07/20/2006 | US20060160152 Protein for use in the treatment of inflammation, allergies, asthma and leukemias |
| 07/20/2006 | US20060160150 Solid phase synthesis; antibodies; kits |
| 07/20/2006 | US20060160147 Recombinant cell line |
| 07/20/2006 | US20060160146 Method of screening compound affecting amyloid beta production |
| 07/20/2006 | US20060160145 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs |
| 07/20/2006 | US20060160142 Phosophoinositoglycan binding proteins |
| 07/20/2006 | US20060160141 Peptide sequence tags and method of using same |
| 07/20/2006 | US20060160140 Human nuclear receptor protein nNR7-1 |